Genomic Valley Biotech Ltd — Updates, 29-07-2025: Company Update

Genomic Valley Biotech Limited has submitted a compliance certificate for the quarter ending June 2025. The certificate, issued by its Registrar and Share Transfer Agent, confirms that all physical securities received for dematerialization were efficiently processed. This includes confirming receipt to depositories, ensuring the shares are listed, and accurately updating the company's register of members within the specified 15-day timeframe. This regular filing assures investors of accurate and timely handling of share conversions, supporting market transparency and investor trust.